Global Acute Pancreatitis Market Size, Status and Forecast 2020-2026

May 2020 | 94 pages | ID: G5592B3A3614EN
QYResearch

Abstracts

This report focuses on the global Acute Pancreatitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Pancreatitis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott Laboratories
• McNeil Consumer Healthcare
• Sun BioPharma
• Atox Bio
• Calcimedica
• D-Pharm Ltd
• Dynavax Technologies
• Glaxosmithkline

Market segment by Type, the product can be split into

• Fluids
• Nutritional Support
• Treatment of Underlying Issues
• Other

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Acute Pancreatitis status, future forecast, growth opportunity, key market and key players.
• To present the Acute Pancreatitis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acute Pancreatitis are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Pancreatitis Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acute Pancreatitis Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fluids
  1.4.3 Nutritional Support
  1.4.4 Treatment of Underlying Issues
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Acute Pancreatitis Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acute Pancreatitis Market Perspective (2015-2026)
2.2 Acute Pancreatitis Growth Trends by Regions
  2.2.1 Acute Pancreatitis Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acute Pancreatitis Historic Market Share by Regions (2015-2020)
  2.2.3 Acute Pancreatitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acute Pancreatitis Market Growth Strategy
  2.3.6 Primary Interviews with Key Acute Pancreatitis Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acute Pancreatitis Players by Market Size
  3.1.1 Global Top Acute Pancreatitis Players by Revenue (2015-2020)
  3.1.2 Global Acute Pancreatitis Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acute Pancreatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Pancreatitis Market Concentration Ratio
  3.2.1 Global Acute Pancreatitis Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acute Pancreatitis Revenue in 2019
3.3 Acute Pancreatitis Key Players Head office and Area Served
3.4 Key Players Acute Pancreatitis Product Solution and Service
3.5 Date of Enter into Acute Pancreatitis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acute Pancreatitis Historic Market Size by Type (2015-2020)
4.2 Global Acute Pancreatitis Forecasted Market Size by Type (2021-2026)

5 ACUTE PANCREATITIS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acute Pancreatitis Market Size by Application (2015-2020)
5.2 Global Acute Pancreatitis Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acute Pancreatitis Market Size (2015-2020)
6.2 Acute Pancreatitis Key Players in North America (2019-2020)
6.3 North America Acute Pancreatitis Market Size by Type (2015-2020)
6.4 North America Acute Pancreatitis Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acute Pancreatitis Market Size (2015-2020)
7.2 Acute Pancreatitis Key Players in Europe (2019-2020)
7.3 Europe Acute Pancreatitis Market Size by Type (2015-2020)
7.4 Europe Acute Pancreatitis Market Size by Application (2015-2020)

8 CHINA

8.1 China Acute Pancreatitis Market Size (2015-2020)
8.2 Acute Pancreatitis Key Players in China (2019-2020)
8.3 China Acute Pancreatitis Market Size by Type (2015-2020)
8.4 China Acute Pancreatitis Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acute Pancreatitis Market Size (2015-2020)
9.2 Acute Pancreatitis Key Players in Japan (2019-2020)
9.3 Japan Acute Pancreatitis Market Size by Type (2015-2020)
9.4 Japan Acute Pancreatitis Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acute Pancreatitis Market Size (2015-2020)
10.2 Acute Pancreatitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Pancreatitis Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Pancreatitis Market Size by Application (2015-2020)

11 INDIA

11.1 India Acute Pancreatitis Market Size (2015-2020)
11.2 Acute Pancreatitis Key Players in India (2019-2020)
11.3 India Acute Pancreatitis Market Size by Type (2015-2020)
11.4 India Acute Pancreatitis Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acute Pancreatitis Market Size (2015-2020)
12.2 Acute Pancreatitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Pancreatitis Market Size by Type (2015-2020)
12.4 Central & South America Acute Pancreatitis Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Acute Pancreatitis Introduction
  13.1.4 Abbott Laboratories Revenue in Acute Pancreatitis Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 McNeil Consumer Healthcare
  13.2.1 McNeil Consumer Healthcare Company Details
  13.2.2 McNeil Consumer Healthcare Business Overview and Its Total Revenue
  13.2.3 McNeil Consumer Healthcare Acute Pancreatitis Introduction
  13.2.4 McNeil Consumer Healthcare Revenue in Acute Pancreatitis Business (2015-2020)
  13.2.5 McNeil Consumer Healthcare Recent Development
13.3 Sun BioPharma
  13.3.1 Sun BioPharma Company Details
  13.3.2 Sun BioPharma Business Overview and Its Total Revenue
  13.3.3 Sun BioPharma Acute Pancreatitis Introduction
  13.3.4 Sun BioPharma Revenue in Acute Pancreatitis Business (2015-2020)
  13.3.5 Sun BioPharma Recent Development
13.4 Atox Bio
  13.4.1 Atox Bio Company Details
  13.4.2 Atox Bio Business Overview and Its Total Revenue
  13.4.3 Atox Bio Acute Pancreatitis Introduction
  13.4.4 Atox Bio Revenue in Acute Pancreatitis Business (2015-2020)
  13.4.5 Atox Bio Recent Development
13.5 Calcimedica
  13.5.1 Calcimedica Company Details
  13.5.2 Calcimedica Business Overview and Its Total Revenue
  13.5.3 Calcimedica Acute Pancreatitis Introduction
  13.5.4 Calcimedica Revenue in Acute Pancreatitis Business (2015-2020)
  13.5.5 Calcimedica Recent Development
13.6 D-Pharm Ltd
  13.6.1 D-Pharm Ltd Company Details
  13.6.2 D-Pharm Ltd Business Overview and Its Total Revenue
  13.6.3 D-Pharm Ltd Acute Pancreatitis Introduction
  13.6.4 D-Pharm Ltd Revenue in Acute Pancreatitis Business (2015-2020)
  13.6.5 D-Pharm Ltd Recent Development
13.7 Dynavax Technologies
  13.7.1 Dynavax Technologies Company Details
  13.7.2 Dynavax Technologies Business Overview and Its Total Revenue
  13.7.3 Dynavax Technologies Acute Pancreatitis Introduction
  13.7.4 Dynavax Technologies Revenue in Acute Pancreatitis Business (2015-2020)
  13.7.5 Dynavax Technologies Recent Development
13.8 Glaxosmithkline
  13.8.1 Glaxosmithkline Company Details
  13.8.2 Glaxosmithkline Business Overview and Its Total Revenue
  13.8.3 Glaxosmithkline Acute Pancreatitis Introduction
  13.8.4 Glaxosmithkline Revenue in Acute Pancreatitis Business (2015-2020)
  13.8.5 Glaxosmithkline Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acute Pancreatitis Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Pancreatitis Revenue
Table 3. Ranking of Global Top Acute Pancreatitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Pancreatitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fluids
Table 6. Key Players of Nutritional Support
Table 7. Key Players of Treatment of Underlying Issues
Table 8. Key Players of Other
Table 9. Global Acute Pancreatitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Acute Pancreatitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Acute Pancreatitis Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Acute Pancreatitis Market Share by Regions (2015-2020)
Table 13. Global Acute Pancreatitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Acute Pancreatitis Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Acute Pancreatitis Market Growth Strategy
Table 19. Main Points Interviewed from Key Acute Pancreatitis Players
Table 20. Global Acute Pancreatitis Revenue by Players (2015-2020) (Million US$)
Table 21. Global Acute Pancreatitis Market Share by Players (2015-2020)
Table 22. Global Top Acute Pancreatitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Pancreatitis as of 2019)
Table 23. Global Acute Pancreatitis by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Pancreatitis Product Solution and Service
Table 26. Date of Enter into Acute Pancreatitis Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 29. Global Acute Pancreatitis Market Size Share by Type (2015-2020)
Table 30. Global Acute Pancreatitis Revenue Market Share by Type (2021-2026)
Table 31. Global Acute Pancreatitis Market Size Share by Application (2015-2020)
Table 32. Global Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 33. Global Acute Pancreatitis Market Size Share by Application (2021-2026)
Table 34. North America Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Acute Pancreatitis Market Share (2019-2020)
Table 36. North America Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 37. North America Acute Pancreatitis Market Share by Type (2015-2020)
Table 38. North America Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 39. North America Acute Pancreatitis Market Share by Application (2015-2020)
Table 40. Europe Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Acute Pancreatitis Market Share (2019-2020)
Table 42. Europe Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Acute Pancreatitis Market Share by Type (2015-2020)
Table 44. Europe Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Acute Pancreatitis Market Share by Application (2015-2020)
Table 46. China Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 47. China Key Players Acute Pancreatitis Market Share (2019-2020)
Table 48. China Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 49. China Acute Pancreatitis Market Share by Type (2015-2020)
Table 50. China Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 51. China Acute Pancreatitis Market Share by Application (2015-2020)
Table 52. Japan Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Acute Pancreatitis Market Share (2019-2020)
Table 54. Japan Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Acute Pancreatitis Market Share by Type (2015-2020)
Table 56. Japan Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Acute Pancreatitis Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Acute Pancreatitis Market Share (2019-2020)
Table 60. Southeast Asia Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Acute Pancreatitis Market Share by Type (2015-2020)
Table 62. Southeast Asia Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Acute Pancreatitis Market Share by Application (2015-2020)
Table 64. India Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 65. India Key Players Acute Pancreatitis Market Share (2019-2020)
Table 66. India Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 67. India Acute Pancreatitis Market Share by Type (2015-2020)
Table 68. India Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 69. India Acute Pancreatitis Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Acute Pancreatitis Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Acute Pancreatitis Market Share (2019-2020)
Table 72. Central & South America Acute Pancreatitis Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Acute Pancreatitis Market Share by Type (2015-2020)
Table 74. Central & South America Acute Pancreatitis Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Acute Pancreatitis Market Share by Application (2015-2020)
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Product
Table 79. Abbott Laboratories Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 80. Abbott Laboratories Recent Development
Table 81. McNeil Consumer Healthcare Company Details
Table 82. McNeil Consumer Healthcare Business Overview
Table 83. McNeil Consumer Healthcare Product
Table 84. McNeil Consumer Healthcare Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 85. McNeil Consumer Healthcare Recent Development
Table 86. Sun BioPharma Company Details
Table 87. Sun BioPharma Business Overview
Table 88. Sun BioPharma Product
Table 89. Sun BioPharma Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 90. Sun BioPharma Recent Development
Table 91. Atox Bio Company Details
Table 92. Atox Bio Business Overview
Table 93. Atox Bio Product
Table 94. Atox Bio Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 95. Atox Bio Recent Development
Table 96. Calcimedica Company Details
Table 97. Calcimedica Business Overview
Table 98. Calcimedica Product
Table 99. Calcimedica Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 100. Calcimedica Recent Development
Table 101. D-Pharm Ltd Company Details
Table 102. D-Pharm Ltd Business Overview
Table 103. D-Pharm Ltd Product
Table 104. D-Pharm Ltd Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 105. D-Pharm Ltd Recent Development
Table 106. Dynavax Technologies Company Details
Table 107. Dynavax Technologies Business Overview
Table 108. Dynavax Technologies Product
Table 109. Dynavax Technologies Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 110. Dynavax Technologies Recent Development
Table 111. Glaxosmithkline Business Overview
Table 112. Glaxosmithkline Product
Table 113. Glaxosmithkline Company Details
Table 114. Glaxosmithkline Revenue in Acute Pancreatitis Business (2015-2020) (Million US$)
Table 115. Glaxosmithkline Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acute Pancreatitis Market Share by Type: 2020 VS 2026
Figure 2. Fluids Features
Figure 3. Nutritional Support Features
Figure 4. Treatment of Underlying Issues Features
Figure 5. Other Features
Figure 6. Global Acute Pancreatitis Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Acute Pancreatitis Report Years Considered
Figure 11. Global Acute Pancreatitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acute Pancreatitis Market Share by Regions: 2020 VS 2026
Figure 13. Global Acute Pancreatitis Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acute Pancreatitis Market Share by Players in 2019
Figure 16. Global Top Acute Pancreatitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Pancreatitis as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acute Pancreatitis Revenue in 2019
Figure 18. North America Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acute Pancreatitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Laboratories Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 27. McNeil Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. McNeil Consumer Healthcare Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 29. Sun BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sun BioPharma Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 31. Atox Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Atox Bio Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 33. Calcimedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Calcimedica Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 35. D-Pharm Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. D-Pharm Ltd Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 37. Dynavax Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Dynavax Technologies Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 39. Glaxosmithkline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Glaxosmithkline Revenue Growth Rate in Acute Pancreatitis Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed